Spots Global Cancer Trial Database for l2 adult acute lymphoblastic leukemia
Every month we try and update this database with for l2 adult acute lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia | NCT00002588 | Leukemia | etoposide topotecan hydro... | 18 Years - | Case Comprehensive Cancer Center | |
| S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT00109837 | Leukemia | filgrastim cyclophosphamid... cytarabine daunorubicin dexamethasone doxorubicin leucovorin mercaptopurine methotrexate mitoxantrone Asparaginase prednisone thioguanine vincristine radiation thera... allopurinol bactrim | 18 Years - 64 Years | SWOG Cancer Research Network | |
| Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia | NCT00061945 | Acute Undiffere... B-cell Adult Ac... B-cell Childhoo... L1 Adult Acute ... L1 Childhood Ac... L2 Adult Acute ... L2 Childhood Ac... Philadelphia Ch... Philadelphia Ch... Philadelphia Ch... T-cell Adult Ac... T-cell Childhoo... Untreated Adult... Untreated Child... | allopurinol cyclophosphamid... daunorubicin hy... vincristine sul... dexamethasone asparaginase filgrastim imatinib mesyla... methotrexate cytarabine trimethoprim-su... mercaptopurine leucovorin calc... alemtuzumab acyclovir laboratory biom... pharmacological... | 15 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT01005758 | Leukemia | cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide phosp... hydrocortisone ... imatinib mesyla... mercaptopurine methotrexate methylprednisol... pegaspargase prednisolone prednisone vincristine sul... laboratory biom... radiation thera... | 18 Years - 50 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia | NCT00003700 | Leukemia | G-CSF asparaginase cyclophosphamid... cytarabine daunorubicin hy... leucovorin calc... mercaptopurine methotrexate prednisone vincristine sul... Allopurinol | 15 Years - | Alliance for Clinical Trials in Oncology | |
| Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | NCT00006008 | Leukemia | arsenic trioxid... | 18 Years - | National Cancer Institute (NCI) | |
| S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia | NCT00006020 | Leukemia | nelarabine | 16 Years - | SWOG Cancer Research Network | |
| SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia | NCT00002665 | Leukemia Neutropenia Thrombocytopeni... | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... etoposide leucovorin calc... mercaptopurine methotrexate prednisone thioguanine vincristine sul... allogeneic bone... radiation thera... | 15 Years - 65 Years | SWOG Cancer Research Network | |
| Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome | NCT00005593 | Leukemia Myelodysplastic... | carboplatin fludarabine pho... topotecan hydro... | 12 Years - | Case Comprehensive Cancer Center | |
| Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT01005758 | Leukemia | cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide phosp... hydrocortisone ... imatinib mesyla... mercaptopurine methotrexate methylprednisol... pegaspargase prednisolone prednisone vincristine sul... laboratory biom... radiation thera... | 18 Years - 50 Years | National Cancer Institute (NCI) | |
| Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia | NCT00458848 | Leukemia | asparaginase daunorubicin hy... etoposide idarubicin imatinib mesyla... mercaptopurine methotrexate methylprednisol... mitoxantrone hy... prednisone vincristine sul... allogeneic hema... autologous hema... peripheral bloo... radiation thera... | 15 Years - 60 Years | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | NCT00945815 | Leukemia | epratuzumab clofarabine cytarabine laboratory biom... | 16 Years - 120 Years | SWOG Cancer Research Network | |
| Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome | NCT00005593 | Leukemia Myelodysplastic... | carboplatin fludarabine pho... topotecan hydro... | 12 Years - | Case Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
